217 related articles for article (PubMed ID: 16115954)
1. Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.
Gross ND; Boyle JO; Morrow JD; Williams MK; Moskowitz CS; Subbaramaiah K; Dannenberg AJ; Duffield-Lillico AJ
Clin Cancer Res; 2005 Aug; 11(16):6087-93. PubMed ID: 16115954
[TBL] [Abstract][Full Text] [Related]
2. Elevated Levels of Urinary PGE-M Are Found in Tobacco Users and Indicate a Poor Prognosis for Oral Squamous Cell Carcinoma Patients.
Kekatpure VD; Bs N; Wang H; Zhou XK; Kandasamy C; Sunny SP; Suresh A; Milne GL; Kuriakose MA; Dannenberg AJ
Cancer Prev Res (Phila); 2016 Jun; 9(6):428-36. PubMed ID: 27045033
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients.
Kekatpure VD; Boyle JO; Zhou XK; Duffield-Lillico AJ; Gross ND; Lee NY; Subbaramaiah K; Morrow JD; Milne G; Lippman SM; Dannenberg AJ
Cancer Prev Res (Phila); 2009 Nov; 2(11):957-65. PubMed ID: 19843689
[TBL] [Abstract][Full Text] [Related]
4. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography-tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E(2) in human urine.
Neale JR; Dean BJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):72-7. PubMed ID: 18632314
[TBL] [Abstract][Full Text] [Related]
6. Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway.
Duffield-Lillico AJ; Boyle JO; Zhou XK; Ghosh A; Butala GS; Subbaramaiah K; Newman RA; Morrow JD; Milne GL; Dannenberg AJ
Cancer Prev Res (Phila); 2009 Apr; 2(4):322-9. PubMed ID: 19336727
[TBL] [Abstract][Full Text] [Related]
7. Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia.
Johnson JC; Schmidt CR; Shrubsole MJ; Billheimer DD; Joshi PR; Morrow JD; Heslin MJ; Washington MK; Ness RM; Zheng W; Schwartz DA; Coffey RJ; Beauchamp RD; Merchant NB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1358-65. PubMed ID: 16996805
[TBL] [Abstract][Full Text] [Related]
8. Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.
Dong LM; Shu XO; Gao YT; Milne G; Ji BT; Yang G; Li HL; Rothman N; Zheng W; Chow WH; Abnet CC
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3075-8. PubMed ID: 19861525
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer.
Morris PG; Zhou XK; Milne GL; Goldstein D; Hawks LC; Dang CT; Modi S; Fornier MN; Hudis CA; Dannenberg AJ
Cancer Prev Res (Phila); 2013 May; 6(5):428-36. PubMed ID: 23531446
[TBL] [Abstract][Full Text] [Related]
10. Urinary PGE-M Levels and Risk of Ovarian Cancer.
Barnard ME; Beeghly-Fadiel A; Milne GL; Akam EY; Chan AT; Eliassen AH; Rosner BA; Shu XO; Terry KL; Xiang YB; Zheng W; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1845-1852. PubMed ID: 31387969
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.
Cui Y; Shu XO; Li HL; Yang G; Wen W; Gao YT; Cai Q; Rothman N; Yin HY; Lan Q; Xiang YB; Zheng W
Int J Cancer; 2017 Dec; 141(12):2423-2429. PubMed ID: 28815606
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.
Khariwala SS; Carmella SG; Stepanov I; Fernandes P; Lassig AA; Yueh B; Hatsukami D; Hecht SS
Head Neck; 2013 Aug; 35(8):1096-100. PubMed ID: 22807150
[TBL] [Abstract][Full Text] [Related]
13. Urinary prostaglandin E2 metabolite and risk for colorectal adenoma.
Shrubsole MJ; Cai Q; Wen W; Milne G; Smalley WE; Chen Z; Ness RM; Zheng W
Cancer Prev Res (Phila); 2012 Feb; 5(2):336-42. PubMed ID: 22166248
[TBL] [Abstract][Full Text] [Related]
14. Significant increase of prostaglandin E-major urinary metabolite in male smokers: a screening study of age and gender differences using a simple radioimmunoassay.
Okayasu I; Ohnishi H; Sarandi I; Shojima J; Komatsu J; Oritsu M; Sasabe M; Nanami KO; Matsuura M; Azumi J; Ito S; Fujiwara M
J Clin Lab Anal; 2014 Jan; 28(1):32-41. PubMed ID: 24375858
[TBL] [Abstract][Full Text] [Related]
15. Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies.
Seyberth HW; Sweetman BJ; Frolich JC; Oates JA
Prostaglandins; 1976 Feb; 11(2):381-97. PubMed ID: 772759
[TBL] [Abstract][Full Text] [Related]
16. Quantification of major urinary metabolites of PGE2 and PGD2 in cystic fibrosis: correlation with disease severity.
Jabr S; Gartner S; Milne GL; Roca-Ferrer J; Casas J; Moreno A; Gelpí E; Picado C
Prostaglandins Leukot Essent Fatty Acids; 2013 Aug; 89(2-3):121-6. PubMed ID: 23791427
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 of the upper aerodigestive tract.
Johnson JT; Rabin BS; Wagner RL
Ann Otol Rhinol Laryngol; 1987; 96(2 Pt 1):213-6. PubMed ID: 3471170
[TBL] [Abstract][Full Text] [Related]
18. Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel.
Csiki I; Morrow JD; Sandler A; Shyr Y; Oates J; Williams MK; Dang T; Carbone DP; Johnson DH
Clin Cancer Res; 2005 Sep; 11(18):6634-40. PubMed ID: 16166442
[TBL] [Abstract][Full Text] [Related]
19. Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women.
Kim S; Taylor JA; Milne GL; Sandler DP
Cancer Prev Res (Phila); 2013 Jun; 6(6):511-8. PubMed ID: 23636050
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk.
Cai Q; Gao YT; Chow WH; Shu XO; Yang G; Ji BT; Wen W; Rothman N; Li HL; Morrow JD; Zheng W
J Clin Oncol; 2006 Nov; 24(31):5010-6. PubMed ID: 17075120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
